longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge

ANI Pharma

ANIP

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
  • Weekly Recap | Revolution Medicines +0.81%, most brokers rate it buy

    Weekly Review·Oct 3, 2026 at 07:37 AM
    RVMD-0.12%
  • Weekly Recap | Roche -4.04%, most brokers rate it buy

    Weekly Review·Oct 3, 2026 at 07:34 AM
    RHHBY+2.78%
  • Weekly Recap | Lexicon Pharma +1.39%, consensus target above spot

    Weekly Review·Oct 3, 2026 at 07:11 AM
    LXRX+0.29%
  • Weekly Recap | Eli Lilly -3.43%, most brokers rate it buy

    Weekly Review·Oct 3, 2026 at 07:08 AM
    LLY+2.50%LLYX+5.00%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy